Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Elizabeth McFarland

Concepts (374)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
26
2025
840
2.950
Why?
HIV Infections
47
2025
2703
2.880
Why?
Respiratory Syncytial Virus Vaccines
6
2022
32
2.420
Why?
Respiratory Syncytial Virus Infections
6
2022
117
2.230
Why?
Respiratory Syncytial Virus, Human
6
2022
68
2.210
Why?
Infectious Disease Transmission, Vertical
17
2025
165
2.150
Why?
HIV Antibodies
12
2025
57
2.110
Why?
Anti-Retroviral Agents
12
2023
230
1.790
Why?
Viral Proteins
3
2020
321
1.630
Why?
Antibodies, Viral
8
2022
593
1.170
Why?
Antibodies, Neutralizing
8
2025
255
1.140
Why?
Antibodies, Monoclonal
6
2025
1355
0.910
Why?
Anti-HIV Agents
11
2025
747
0.900
Why?
AIDS Vaccines
8
2018
47
0.890
Why?
Pregnancy Complications, Infectious
8
2016
335
0.810
Why?
Gene Deletion
2
2020
372
0.750
Why?
Breast Feeding
4
2025
421
0.670
Why?
Atazanavir Sulfate
2
2017
41
0.660
Why?
HIV Protease Inhibitors
2
2017
61
0.640
Why?
Ritonavir
2
2017
72
0.630
Why?
Vaccination
6
2020
1336
0.600
Why?
Infant, Newborn
23
2025
5687
0.600
Why?
Vaccines, Attenuated
6
2022
123
0.600
Why?
HIV Envelope Protein gp120
6
2017
57
0.590
Why?
Infant
31
2025
8913
0.540
Why?
Nelfinavir
1
2016
8
0.520
Why?
Lopinavir
1
2016
30
0.510
Why?
Syncope
1
2016
50
0.510
Why?
Patient Dropouts
1
2016
65
0.510
Why?
Bradycardia
1
2016
55
0.510
Why?
Lyme Disease
1
2016
50
0.500
Why?
Health Resources
1
2016
120
0.480
Why?
Infant, Newborn, Diseases
1
2016
108
0.460
Why?
HIV
5
2014
226
0.430
Why?
Patient Compliance
2
2018
562
0.420
Why?
Immunogenicity, Vaccine
4
2021
26
0.400
Why?
Child
36
2023
20721
0.380
Why?
CD4-Positive T-Lymphocytes
2
2017
1046
0.370
Why?
T-Lymphocytes, Cytotoxic
4
2005
168
0.370
Why?
Virus Replication
4
2020
444
0.370
Why?
Humans
71
2025
128524
0.360
Why?
Female
47
2025
68127
0.350
Why?
Lymphocyte Activation
5
2017
1098
0.320
Why?
Male
38
2025
62883
0.310
Why?
Viral Load
9
2017
450
0.290
Why?
HIV Seropositivity
2
2023
119
0.280
Why?
Adolescent
26
2023
20213
0.280
Why?
Double-Blind Method
3
2020
1860
0.270
Why?
RNA, Viral
8
2023
614
0.270
Why?
Antibodies, Bacterial
2
2018
136
0.250
Why?
Antiretroviral Therapy, Highly Active
6
2017
266
0.240
Why?
Dyslipidemias
2
2017
177
0.240
Why?
Immunoenzyme Techniques
1
2005
206
0.230
Why?
Immunoglobulin G
3
2022
837
0.230
Why?
Colonography, Computed Tomographic
1
2024
6
0.220
Why?
Viremia
3
2011
130
0.220
Why?
Diverticulum
1
2024
11
0.220
Why?
Child, Preschool
21
2022
10373
0.220
Why?
Gene Products, gag
2
1994
36
0.220
Why?
Mammography
1
2025
143
0.220
Why?
Young Adult
12
2021
12320
0.210
Why?
Pregnancy
11
2023
6297
0.210
Why?
Squalene
3
2017
7
0.210
Why?
Complementarity Determining Regions
1
2002
49
0.200
Why?
Drug Resistance, Viral
2
2016
111
0.190
Why?
CD4 Lymphocyte Count
4
2017
265
0.190
Why?
Half-Life
1
2021
144
0.190
Why?
Growth Differentiation Factor 15
1
2021
39
0.190
Why?
Mitochondrial Diseases
1
2021
89
0.180
Why?
Immunization Schedule
2
2018
197
0.180
Why?
T-Lymphocytes
2
2009
1922
0.180
Why?
Drug Therapy, Combination
4
2017
1009
0.180
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.170
Why?
Fibroblast Growth Factors
1
2021
171
0.170
Why?
RNA, Small Untranslated
1
2020
15
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.170
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
185
0.160
Why?
Cytokines
2
2021
1985
0.160
Why?
Body Temperature
1
2020
215
0.160
Why?
Point Mutation
1
2020
224
0.160
Why?
Immunologic Memory
2
2021
339
0.150
Why?
Insulin Resistance
3
2019
1166
0.150
Why?
Haemophilus Vaccines
2
2018
28
0.150
Why?
Immunocompromised Host
2
2000
195
0.150
Why?
CD8-Positive T-Lymphocytes
2
2011
840
0.150
Why?
Metabolic Syndrome
1
2021
340
0.150
Why?
Darunavir
1
2017
17
0.140
Why?
Interleukin-12
1
1998
120
0.140
Why?
Dose-Response Relationship, Drug
1
2021
1943
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Interferon-gamma
5
2012
761
0.140
Why?
Immunoglobulin A
2
2017
192
0.140
Why?
Uganda
1
2017
72
0.140
Why?
Antibody Formation
1
2018
287
0.140
Why?
Lymphopoiesis
1
2017
26
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
377
0.140
Why?
High-Throughput Screening Assays
1
2018
136
0.140
Why?
Receptors, CCR5
1
2017
58
0.140
Why?
CD4-CD8 Ratio
1
2016
22
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
12
0.130
Why?
Adoption
1
2016
33
0.130
Why?
Mothers
3
2017
728
0.130
Why?
Virus Latency
1
2016
77
0.130
Why?
Adult
15
2023
35315
0.120
Why?
Chickenpox Vaccine
1
2015
71
0.120
Why?
Continuity of Patient Care
1
2018
278
0.120
Why?
Early Diagnosis
1
2016
236
0.120
Why?
Body Height
2
2017
192
0.120
Why?
Zimbabwe
2
2025
54
0.120
Why?
Gene Products, env
1
1994
6
0.120
Why?
Disease Susceptibility
1
2017
334
0.120
Why?
Haemophilus influenzae type b
1
2014
10
0.120
Why?
Bacterial Capsules
1
2014
28
0.120
Why?
Chickenpox
1
2015
78
0.120
Why?
Antibody Affinity
1
2014
59
0.120
Why?
South Africa
2
2025
192
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
222
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
Vaccines, Synthetic
4
2005
126
0.110
Why?
Developing Countries
1
2016
283
0.110
Why?
Lipids
1
2017
624
0.110
Why?
Puberty, Delayed
1
2013
5
0.110
Why?
Cytotoxicity, Immunologic
3
2002
218
0.110
Why?
Intestines
1
2017
345
0.110
Why?
Leukocytes, Mononuclear
4
2013
538
0.110
Why?
Retrospective Studies
8
2023
14460
0.110
Why?
Vaccines
1
2018
393
0.110
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.110
Why?
Patient Selection
1
2017
661
0.100
Why?
Mycobacterium chelonae
1
1993
9
0.100
Why?
Breast Neoplasms
1
2025
2139
0.100
Why?
Mitochondria
2
2021
844
0.100
Why?
Lamivudine
3
2023
61
0.100
Why?
Cohort Studies
7
2021
5369
0.100
Why?
Bone Density
1
2016
476
0.100
Why?
Cell Movement
1
2017
937
0.100
Why?
Child Development
1
2017
452
0.100
Why?
Pediatric Obesity
1
2019
572
0.100
Why?
Clinical Trials as Topic
1
2017
998
0.100
Why?
Cardiovascular Diseases
2
2016
2018
0.100
Why?
STAT1 Transcription Factor
1
2012
70
0.100
Why?
Prospective Studies
4
2017
7043
0.100
Why?
Body Weight
2
2017
931
0.090
Why?
Polysorbates
3
2017
38
0.090
Why?
Body Fat Distribution
1
2011
49
0.090
Why?
Mycobacterium avium Complex
1
2012
90
0.090
Why?
Epitopes
2
2022
466
0.090
Why?
United States
9
2023
13876
0.090
Why?
Cost-Benefit Analysis
2
2025
581
0.090
Why?
Research Design
1
2017
1038
0.090
Why?
Biomedical Research
1
2017
646
0.090
Why?
Interleukin-2
2
2003
430
0.080
Why?
Exercise
1
2021
1937
0.080
Why?
Respiratory Tract Infections
1
2014
370
0.080
Why?
Prenatal Exposure Delayed Effects
1
2016
551
0.080
Why?
Freezing
1
2009
86
0.080
Why?
Blood
1
2009
100
0.080
Why?
Algorithms
1
2016
1616
0.080
Why?
Staff Development
1
2009
56
0.080
Why?
Age Factors
4
2019
3117
0.080
Why?
Phenotype
1
2017
3050
0.070
Why?
Biomarkers
4
2021
3881
0.070
Why?
T-Lymphocyte Subsets
2
2002
410
0.070
Why?
Specimen Handling
1
2009
165
0.070
Why?
Lymphocyte Subsets
2
2009
85
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
814
0.070
Why?
Faculty
1
2009
135
0.070
Why?
Withholding Treatment
1
2008
70
0.070
Why?
Adipose Tissue
1
2011
591
0.070
Why?
Enterovirus A, Human
1
2007
12
0.070
Why?
Polymerase Chain Reaction
4
2011
1019
0.070
Why?
Central Nervous System Viral Diseases
1
2007
73
0.070
Why?
Flow Cytometry
3
2009
1141
0.060
Why?
Academic Medical Centers
1
2009
473
0.060
Why?
DNA, Viral
2
2000
348
0.060
Why?
False Negative Reactions
1
2025
50
0.060
Why?
Isoantigens
1
1984
12
0.060
Why?
Cell Line
3
2012
2731
0.060
Why?
Medical Audit
1
2025
76
0.060
Why?
C-Reactive Protein
2
2021
396
0.060
Why?
Enterovirus Infections
1
2007
171
0.060
Why?
Colorado
3
2023
4392
0.060
Why?
Disease Outbreaks
1
2007
334
0.060
Why?
Immunity, Cellular
1
2006
267
0.060
Why?
Follow-Up Studies
3
2021
4898
0.060
Why?
Linear Models
2
2020
816
0.060
Why?
Confusion
1
2024
27
0.050
Why?
Comorbidity
2
2021
1540
0.050
Why?
Sequence Analysis, DNA
2
2007
773
0.050
Why?
Thymus Gland
1
1984
309
0.050
Why?
Risk Factors
4
2021
9727
0.050
Why?
Tablets
1
2023
37
0.050
Why?
Constriction, Pathologic
1
2024
229
0.050
Why?
Regression Analysis
2
2021
983
0.050
Why?
Respiratory Syncytial Viruses
1
2022
52
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
21
0.050
Why?
Immunophenotyping
2
1994
312
0.050
Why?
Zidovudine
2
2015
77
0.050
Why?
Clone Cells
1
2002
254
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
81
0.050
Why?
Cough
1
2022
116
0.050
Why?
Emtricitabine
1
2023
168
0.050
Why?
Vaccines, Subunit
1
2001
47
0.050
Why?
Tenofovir
1
2023
231
0.050
Why?
Pyridones
1
2023
159
0.050
Why?
Lung
1
2014
3741
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
49
0.050
Why?
Public Health Surveillance
1
2021
67
0.040
Why?
Ganciclovir
1
2000
51
0.040
Why?
Computer Simulation
1
2005
939
0.040
Why?
Adjuvants, Immunologic
2
2017
221
0.040
Why?
Africa
1
2020
98
0.040
Why?
Injections, Subcutaneous
1
2020
145
0.040
Why?
Cross-Sectional Studies
3
2021
5040
0.040
Why?
Sex Factors
2
2019
1949
0.040
Why?
Diagnostic Tests, Routine
1
2021
103
0.040
Why?
Symptom Assessment
1
2021
125
0.040
Why?
HIV Seronegativity
1
2019
25
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Risk
1
2021
852
0.040
Why?
Case-Control Studies
2
2019
3326
0.040
Why?
Prevalence
2
2016
2549
0.040
Why?
Cytomegalovirus Infections
1
2000
187
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
48
0.040
Why?
Hospitals
1
2023
631
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
42
0.040
Why?
Vaccines, Combined
1
2018
48
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
22
0.040
Why?
Cholesterol, HDL
1
2019
203
0.040
Why?
Amino Acid Sequence
1
2002
2041
0.040
Why?
Longitudinal Studies
2
2017
2697
0.040
Why?
Mutation
3
2018
3692
0.040
Why?
Odds Ratio
1
2021
1022
0.040
Why?
Hepatitis B Vaccines
1
2018
48
0.040
Why?
Drug Resistance, Microbial
2
2000
63
0.040
Why?
Molecular Sequence Data
1
2002
2818
0.040
Why?
Case Management
1
2018
63
0.040
Why?
Nutrition Surveys
1
2019
262
0.040
Why?
Antigens, Viral
1
1998
174
0.040
Why?
Cholesterol
1
2019
406
0.030
Why?
Cholesterol, LDL
1
2019
361
0.030
Why?
Reproducibility of Results
1
2005
3023
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
185
0.030
Why?
Immune Tolerance
1
1999
345
0.030
Why?
Treatment Adherence and Compliance
1
2017
22
0.030
Why?
Disease Management
1
2021
588
0.030
Why?
Triglycerides
1
2019
524
0.030
Why?
Lymphocyte Count
2
2009
150
0.030
Why?
Cell Division
1
1998
779
0.030
Why?
Uncertainty
1
2017
114
0.030
Why?
Treatment Failure
1
2017
342
0.030
Why?
Multicenter Studies as Topic
1
2017
285
0.030
Why?
Nevirapine
1
2015
16
0.030
Why?
Time-to-Treatment
1
2017
180
0.030
Why?
Seroepidemiologic Studies
1
2015
156
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1358
0.030
Why?
Maternal Exposure
1
2017
173
0.030
Why?
Malnutrition
1
2016
78
0.030
Why?
Patient Outcome Assessment
1
2016
127
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Antiviral Agents
1
2000
704
0.030
Why?
Treatment Outcome
2
2021
10163
0.030
Why?
Coinfection
1
2016
131
0.030
Why?
Neutropenia
1
2015
136
0.030
Why?
Vaccines, Conjugate
1
2014
63
0.030
Why?
Counseling
1
2018
386
0.030
Why?
Sexual and Gender Minorities
1
2018
186
0.030
Why?
Global Health
1
2017
326
0.030
Why?
Cells, Cultured
2
2008
4008
0.030
Why?
Anemia
1
2015
156
0.030
Why?
Maternal-Fetal Exchange
1
2014
161
0.030
Why?
Electron Transport Complex IV
1
2013
57
0.030
Why?
Electron Transport Complex I
1
2013
38
0.030
Why?
Thrombocytopenia
1
2015
182
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
30
0.030
Why?
Radiography, Thoracic
1
2014
163
0.030
Why?
CD8 Antigens
1
1993
75
0.030
Why?
Severity of Illness Index
1
2021
2736
0.030
Why?
CD3 Complex
1
1993
101
0.030
Why?
Drug Administration Schedule
2
2008
757
0.030
Why?
Lymphocytes
1
1994
366
0.030
Why?
Oxidative Phosphorylation
1
2013
184
0.020
Why?
Medication Adherence
1
2017
573
0.020
Why?
Blood Pressure
1
2019
1733
0.020
Why?
DNA, Mitochondrial
1
2013
192
0.020
Why?
Blood Transfusion
1
1994
293
0.020
Why?
P-Selectin
1
2011
26
0.020
Why?
Antigens, CD
1
1994
479
0.020
Why?
E-Selectin
1
2011
53
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Tuberculosis, Pulmonary
1
1993
137
0.020
Why?
Chemokine CCL2
1
2011
117
0.020
Why?
Hospitalization
1
2021
2071
0.020
Why?
Cell Proliferation
2
2009
2335
0.020
Why?
Hyperlipidemias
1
2011
126
0.020
Why?
Fibrinogen
1
2011
158
0.020
Why?
Protein Multimerization
1
2012
178
0.020
Why?
Cross Infection
1
1993
196
0.020
Why?
Absorptiometry, Photon
1
2011
250
0.020
Why?
Interferon-alpha
1
2012
192
0.020
Why?
Cell Adhesion Molecules
1
2011
172
0.020
Why?
Healthcare Disparities
1
2017
576
0.020
Why?
Infant, Premature
1
1994
536
0.020
Why?
Nontuberculous Mycobacteria
1
1993
228
0.020
Why?
Diagnosis, Differential
1
2014
1416
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
L-Selectin
1
2009
24
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
35
0.020
Why?
Leukocyte Common Antigens
1
2009
81
0.020
Why?
Obesity
1
2021
2860
0.020
Why?
Multivariate Analysis
1
2011
1494
0.020
Why?
Meningitis, Aseptic
1
2007
14
0.020
Why?
Virus Cultivation
1
2007
28
0.020
Why?
Interleukin-6
1
2011
716
0.020
Why?
Phosphorylation
1
2012
1681
0.020
Why?
Data Interpretation, Statistical
1
2009
335
0.020
Why?
Pregnancy Outcome
1
2010
383
0.020
Why?
Cerebrospinal Fluid
1
2007
89
0.020
Why?
Multiple Organ Failure
1
2007
121
0.020
Why?
Paralysis
1
2007
72
0.020
Why?
B-Lymphocytes
1
2012
820
0.020
Why?
Kinetics
1
2010
1616
0.020
Why?
Respiratory System
1
2007
153
0.020
Why?
Genotype
1
2011
1831
0.020
Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
Why?
Cell Survival
1
2009
1077
0.020
Why?
Phosphates
1
1987
167
0.020
Why?
Muscles
1
1987
323
0.020
Why?
Encephalitis
1
2007
132
0.020
Why?
Gastrointestinal Tract
1
2007
182
0.020
Why?
Mucous Membrane
1
2005
120
0.010
Why?
Chemistry, Physical
1
1984
37
0.010
Why?
Antigen-Antibody Reactions
1
1984
51
0.010
Why?
Chemical Phenomena
1
1984
80
0.010
Why?
DNA-Binding Proteins
1
2012
1415
0.010
Why?
Myasthenia Gravis
1
1984
22
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
62
0.010
Why?
Saliva
1
2005
205
0.010
Why?
Tomography, X-Ray Computed
1
2014
2521
0.010
Why?
Tissue Distribution
1
1984
290
0.010
Why?
Aging
2
2003
1770
0.010
Why?
Blood Glucose
1
2013
2092
0.010
Why?
Epithelium
1
1984
306
0.010
Why?
Middle Aged
2
2020
30893
0.010
Why?
Body Mass Index
1
2011
2262
0.010
Why?
Anti-Bacterial Agents
1
1993
1667
0.010
Why?
Infusions, Intravenous
1
2003
384
0.010
Why?
Reference Values
1
2003
780
0.010
Why?
Mice, Inbred BALB C
1
1984
1229
0.010
Why?
Suspensions
1
2000
30
0.010
Why?
Capsules
1
2000
37
0.010
Why?
Urban Population
1
2003
438
0.010
Why?
Drug Tolerance
1
2000
82
0.010
Why?
Cytomegalovirus
1
2000
153
0.010
Why?
Signal Transduction
1
2012
4829
0.010
Why?
Administration, Oral
1
2000
757
0.010
Why?
Epithelial Cells
1
1984
1036
0.010
Why?
Immunization
1
2000
411
0.010
Why?
Time Factors
1
2008
6503
0.010
Why?
Macrophages
1
1984
1463
0.010
Why?
Recombinant Proteins
1
2000
1284
0.010
Why?
Mice
1
1984
16579
0.000
Why?
Tail
1
1987
29
0.000
Why?
Phosphocreatine
1
1987
40
0.000
Why?
Salamandridae
1
1987
26
0.000
Why?
Animals
2
1987
34501
0.000
Why?
Aged
1
1984
21971
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
508
0.000
Why?
Adenosine Triphosphate
1
1987
470
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)